Title |
Involvement of Brd4 in different steps of the papillomavirus life cycle
|
---|---|
Published in |
Virus Research, December 2016
|
DOI | 10.1016/j.virusres.2016.12.006 |
Pubmed ID | |
Authors |
Thomas Iftner, Juliane Haedicke-Jarboui, Shwu-Yuan Wu, Cheng-Ming Chiang |
Abstract |
Bromodomain-containing protein 4 (Brd4) is a cellular chromatin-binding factor and transcriptional regulator that recruits sequence-specific transcription factors and chromatin modulators to control target gene transcription. Papillomaviruses (PVs) have evolved to hijack Brd4's activity in order to create a facilitating environment for the viral life cycle. Brd4, in association with the major viral regulatory protein E2, is involved in multiple steps of the PV life cycle including replication initiation, viral gene transcription, and viral genome segregation and maintenance. Phosphorylation of Brd4, regulated by casein kinase II (CK2) and protein phosphatase 2A (PP2A), is critical for viral gene transcription as well as E1- and E2-dependent origin replication. Thus, pharmacological agents regulating Brd4 phosphorylation and inhibitors blocking phospho-Brd4 functions are promising candidates for therapeutic intervention in treating human papillomavirus (HPV) infections as well as associated disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 57 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 21% |
Student > Master | 9 | 16% |
Researcher | 9 | 16% |
Student > Doctoral Student | 3 | 5% |
Professor | 2 | 4% |
Other | 4 | 7% |
Unknown | 18 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 12 | 21% |
Medicine and Dentistry | 8 | 14% |
Agricultural and Biological Sciences | 7 | 12% |
Immunology and Microbiology | 3 | 5% |
Engineering | 2 | 4% |
Other | 5 | 9% |
Unknown | 20 | 35% |